المؤلفون: Tang T; Division of Medical Oncology, National Cancer Centre Singapore. Tiffany.Tang.P.L@singhealth.com.sg., Martin P; Division of Medicine, Weill Cornell Medical College, New York., Somasundaram N; Division of Medical Oncology, National Cancer Centre Singapore., Lim C; Division of Clinical Trials and Epidemiology, National Cancer Centre Singapore., Tao M; Division of Medical Oncology, National Cancer Centre Singapore., Poon E; Division of Medical Oncology, National Cancer Centre Singapore., Yunon MJ; Division of Clinical Trials and Epidemiology, National Cancer Centre Singapore., Toh SQ; Division of Clinical Trials and Epidemiology, National Cancer Centre Singapore., Yan SX; Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital., Farid M; Division of Medical Oncology, National Cancer Centre Singapore., Chan JY; Division of Medical Oncology, National Cancer Centre Singapore., Lim ST; Division of Medical Oncology, National Cancer Centre Singapore.

المصدر: Haematologica [Haematologica] 2021 Dec 01; Vol. 106 (12), pp. 3170-3175. Date of Electronic Publication: 2021 Dec 01.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Ifosfamide*/adverse effects , Lymphoma, T-Cell*, Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carboplatin/adverse effects ; Dexamethasone ; Etoposide/adverse effects ; Humans ; Hydrazines ; Neoplasm Recurrence, Local ; Triazoles